The findings were true regardless of tumor type, size or cancer stage, wrote Pragya A. Dang, MD, and colleagues at Brigham and Women’s Hospital in Boston.
The global market for implantable pacemakers is projected to see moderate, steady growth through 2023, resulting in a sum of more than $5.32 billion, according to a recent report.
New assistive technology developed by one Canadian university could serve as a “computational second opinion” for busy radiologists assessing difficult-to-diagnose collapsed lungs, experts said this week.
Despite the Trump administration’s battle cry to cut regulation and reduce paperwork for healthcare organizations, more medical practices say regulatory burdens are worse. And they’ve named prior authorization as the worst regulatory offender.
AI technologies are making a significant impact on the health of patients throughout Asia, according to a new report from MIT Technology Review Insights.
A study of thousands of individuals in Canada suggests the use of angiotensin receptor blockers—as opposed to ACE inhibitors—could be linked to an increased risk of suicide and poor mental health.
Results from a study published Oct. 14 in Nature Communications showed the tracer could identify pancreatic, cervical and lung cancer, in addition to a lung tissue disease called idiopathic pulmonary fibrosis.
Ziv Haskal, MD, an interventional radiologist with the University of Virginia Health System, has created an 11-minute virtual reality experience for docs, detailing a less-invasive treatment for thyroid patients.
